Molecular Biology Professionals to Know 2025

I am the Co-Founder and Chief Product Officer at Mantalys, an AI start-up based in Toulouse, France dedicated to bringing lightweight, high-performance AI solutions to biomedical image analysis. With a PhD in neuro-immunology and five years of post-doctoral research experience in tumor immunology, I bring deep biomedical expertise to the computer vision team - bridging science and technology to unlock real world insights and extract actionable intelligence from biomedical images.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Independent neuroscience researcher and founder of PinealCode.com, where I publish evidence-based articles on pineal gland health, sleep science, and supplementation. My work covers fluoride accumulation in brain tissue, melatonin biochemistry, calcification mechanisms, and supplement efficacy — all referenced against primary literature from PubMed, NIH, Nature, and BMJ. Available to comment on brain health, sleep disorders, detoxification protocols, and the science behind popular wellness claims.

R.G.C.C. International GmbH is a leading company in analysis of circulating tumor cells as well as Cancer Stem Cells.Through our high quality analysis at R.G.C.C. International GmbH we are able to offer a full ranges of services to the R & D, clinical, and pharmaceutical industry.By using the most advanced and innovative technologies of molecular and cellular

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.

Ilya J. Finkelstein, PhD is a Professor of Molecular Biosciences at The University of Texas at Austin specializing in gene editing, biophysics, and biotechnology. He has published 100+ peer-reviewed papers, holds multiple patents, and has served as an expert witness and technical consultant. His work appears frequently in scientific and popular press.

Ali Morgan is the founder of Jonomor, the practice that defines AI Visibility, Answer Engine Optimization (AEO), and Generative Engine Optimization (GEO). He architects entity graphs, schema systems, and authority networks that make companies retrievable by AI answer engines including ChatGPT, Perplexity, and Gemini. Based in Brooklyn, NY, Ali leads an ecosystem of eight properties built on the infrastructure-first principle: own the knowledge graph before you compete for the answer.

I’m an Academic Neuroscientist, Published Author, and the Founder of Sci-translate with a PhD in Neuroscience & Psychology from King’s College London. I founded Sci-translate to empower people with the knowledge to become happier and healthier. Scientific discoveries have the potential to improve millions of people’s lives, but these discoveries often become lost in translation between academia and the real world. That’s why I help purpose-driven ventures understand how to interpret research and create actionable solutions from data. Whether you’re an established business or a start-up, I work with anyone who is passionate about making a positive difference in people’s health and wellbeing.

In my role, I meticulously oversee various clinical projects, ensuring each phase is executed with precision and in compliance with GCP standards. Core Competencies: Clinical Trials Monitoring Clinical Safety Protocols Streamlined Clinical Operations Regulatory Compliance Mastery Educational Background: MSc in Molecular Science and Nanotechnology, Louisiana Tech University MSc in Medical Genetics, MGM University of Health Sciences With a robust educational foundation and a keen eye for detail, I have successfully navigated through different therapeutic areas and regions, delivering high-quality results consistently. My journey in the realm of clinical research is driven by an insatiable curiosity and a deep-seated commitment to advancing science and practice. Let’s Connect! If you are passionate about transforming health care and improving patient lives, or if you wish to exchange insights and collaborate on projects, feel free to connect with me. Together, let’s contribute to a healthier, more understanding world for individuals navigating through challenges.

Dr. Robin Alexander, an MD Pathologist and passionate guitarist, combines his love for music and science. As a guitar enthusiast, he shares valuable insights and tips on guitar playing here at Guitarmetrics, helping musicians enhance their skills and enjoy their musical journey. Visit his linkedin page here. At Guitarmetrics, we take pride in curating creative guitar products like our Guitarcamz™ Guitar Headstock Camera Mount and the one-of-a-kind guitar pick punch. But what truly sets us apart is our dedication to the art of storytelling and knowledge-sharing through our blog. Here, you’ll find expert advice, in-depth reviews, and inspiring stories about the guitar world. We’re passionate about fostering a global community of musicians and writers. That’s why we actively welcome contributors from all over the world to share their insights, experiences, and ideas on Guitarmetrics. Whether you’re a guitarist with a story to tell or a writer looking to inspire others, we invite you to join us in creating a rich tapestry of guitar-related content.

I am an entrepreneur in the medical industry working on creating a new way to approach healthcare and wellness. The company is called Selph, it is a healthcare revolution to provide individuals with the tools to optimise their health. I am a trained General Practitioner and prior to my medical training I completed a PhD looking at the impact of nutrition and probiotic supplementation on metabolism and the developing immune system. I am fascinated by the interaction between the microbiome and health and was a past member of the science translational committee for the International Scientific Association for Probiotics and Prebiotics as well as a founding member of the International Cancer Microbiome Consortium. During my clinical training I became excited in the importance of the mind in physical health and vice versa and so I trained as an accredited mindfulness teacher specialising in mindfulness for stress and mindfulness for chronic pain.

With over 15 years of hands-on experience in affiliate marketing, e-commerce, and digital growth strategy, I’ve helped brands scale profitable online partnerships and build high-performing affiliate ecosystems. As the founder of BestAIFor.com - a fast-growing AI tools directory, benchmark platform, and independent review hub - I now combine my performance marketing background with deep expertise in the AI landscape. I personally evaluate and benchmark hundreds of AI tools every month, tracking real-world metrics like speed, accuracy, pricing shifts, ROI, and usability across productivity, content, marketing, and creative workflows. My work focuses on cutting through the hype to deliver actionable, data-backed insights that help solopreneurs, marketers, and businesses choose the right AI stack for 2026 and beyond. Whether I'm setting up affiliate programs for AI tool makers, optimizing campaign performance with AI-powered automation, or identifying emerging trends through original benchmarks, I’m driven by one goal: turning complex technology into practical growth advantages. I’m passionate about sharing transparent, no-BS analysis and helping the industry move faster with better information. You’ll often find me publishing fresh benchmarks, “State of AI Tools” micro-reports, and strategic guides on BestAIFor.com.

Dr. Paul Durham is distinguished professor of biology and director of Missouri State University's Center for Biomedical and Life Sciences, a multidisciplinary laboratory that utilizes cellular/molecular, microbiological, biochemical and chemical techniques. A primary goal of his research is to determine the signaling pathways by which inflammatory and anti-inflammatory agents control neuropeptide gene expression in disorders involving the trigeminal nerve. Currently, he is studying the regulation of protein expression in cultured nerve and glial cells, human cell lines, in vivo animal models and clinical studies. A major focus of his research has been to elucidate the cellular/molecular mechanisms by which novel drugs and nutraceuticals modulate the excitability state of neurons and glial cells under pathological conditions in models of migraine, TMJ disorder and epilepsy. More recently, his laboratory has been investigating epigenetic mechanisms and changes in gut microbiota in response to changes in diet, sleep pattern, stress and chronic inflammation. Durham is frequently invited as a guest lecturer. He has authored or co-authored 80 peer-reviewed research publications, numerous book chapters and technical reports, and 160 published abstracts. He has received nearly $14 million in external grants to support his research. In addition, Durham has served on numerous National Institutes of Health (NIH) study sections and advisory boards, and is currently a reviewer for 15 different journals.